• Saturday 07 October 2017
  • 08:00
    Diagnostic Symposium
    | More info
  • 09:00
    Plenary session 2 - TOP 10 papers in Mycology
  • 09:00
    PS2.1 Clinical mycology

    Bart-Jan Kullberg, NL
  • 09:00
    PS2.2 Diagnostic mycology

    Katrien Lagrou, BE, FECMM
  • 10:00
    Coffee break
  • Meet the expert sessions
    • 10:15
      M1 Eucast susceptibility testing: Tips and Trics

      Maiken Arendrup, DK / Sevtap Arikan-Akdagli, TR, FECMM
    • 10:15
      M2 MALDI TOF: which platform to use?

      Valérie Monnin, BioMerieux, FR / Markus Kostrzewa, Bruker, DE
    • 10:15
      M3 Fungal keratitis

      Matthew Burton, UK/ Cathrien Eggink, NL
    • 10:15
      M4 Therapeutic drug monitoring of azoles

      Russell Lewis, IT / Isabel Spriet, BE
  • 11:00
    Poster session
  • 12:00
    Lunch break
  • 12:30
    Sponsored Integrated Symposium 2
    | More info
  • 14:15
    Symposia
  • S5: Difficult to diagnose fungal infections
    • 14:15
      S05.1 Mucormycosis

      Laurence Millon, FR
    • 14:15
      S05.2 Non-fungaemic candidosis

      Neil Clancy, US
    • 14:15
      S05.3 Chronic pulmonary aspergillosis

      George Dimopoulos, GR
    • 14:15
      S05.4* Selected abstract: Fusarium species complexes and disease presentation in humans: preliminary analysis of 155 cases from a 5-yr prospective surveillance in France

      Stephane Bretagne, France
  • S6: Fungal adaptation to the lung environment
    • 14:15
      S06.1 Adaptation of fungi to new environments: an evolutionary biologists view

      Bas Zwaan, NL
    • 14:35
      S06.2 Biofilm as fungal adaptation strategy

      Ranjith Rajendran, UK
    • 14:55
      S06.3 In host adaptation of Aspergillus fumigatus

      Paul Verweij, NL, FECMM
    • 15:15
      S06.4 The microbiome-metabolome crosstalk in the pathogenesis of invasive aspergillosis

      Agostinho Carvalho, PT, FECMM
  • S7: ECMM/EFISG symposium: Multidrug resistance in fungi? A formidable foe
    • 14:15
      S07.1 Resistance epidemiology

      Ana Alastruey-Izquierdo, ES, FECMM
    • 14:40
      S07.2 Mechanism of multidrug resistance

      Maurizio Sanguinetti, IT
    • 15:05
      S07.3 Clinical implications

      Matteo Bassetti, IT
    • 15:30
      Discussion
  • S8: FREE COMMUNICATIONS 1

    Accepted Abstracts
    • 14:15
      S08.1 The molecular mechanism of resistance to short-tailed azoles in mucormycetes

      Michaela Lackner, Austria
    • 14:25
      S08.2 Multilocus sequence typing of C. africana from vulvoaginal candidiasis

      S. Fan, China
    • 14:35
      S08.3 Immune parameters of pulmonary infection with the mucormycete species Lichtheimia corymbifera and Rhizopus arrhizus

      Cornelia Speth, Austria
    • 14:45
      S08.4 Invasive pulmonary aspergillosis complicating influenza pneumonia in the ICU: a multicentre observational case-control study

      Alexander Schauwvlieghe, the Netherlands
    • 14:55
      S08.5 Antifungal susceptibility of emerging dimorphic fungal pathogens in the Ajellomycetaceae

      Karolina Dukik, the Netherlands
    • 15:05
      S08.6 Little impact of changes in antifungal drugs prescription on candidemia prognosis and epidemiology in adult patients: results from a 12-year survey in the Paris area

      Stephanie Bretagne, France
    • 15:15
      S08.7 Diagnosis of histoplasmosis : switching from microscopy/culture to RNA/DNA detection

      Alexandre Alanio, France
    • 15:25
      S08.8 Clinical spectrum and outcomes of Candida auris: a single center experience

      Sued Faisal Mahmood, Pakistan
    • 15:35
      S08.9 Longitudinal follow-up of Aspergillus colonization and sensitization in COPD patients: relationship with domestic mold exposure

      Emilie Frealle, France
  • 15:45
    Coffee break
  • 16:15
    Symposia
  • S9: New PJP guidelines
    • 16:15
      S09.1 Epidemiology & Prevention

      Johan Maertens, BE, FECMM
    • 16:40
      S09.2 Diagnosis of Pneumocystis jirovecii pneumonia

      Alexandre Alanio, FR, FECMM
    • 17:05
      S09.3 Treatment

      Jannik Helweg-Larsen, DK
    • 17:30
      S09.4* Selected abstract: Pneumocystis jirovecii pneumonia: late and potentially fatal complication among kidney transplant recipients

      Daniel Wagner Santos, Brazil
  • S10: EORTC / EFISG
    • 16:15
      S10.1 New risk groups

      Livio Pagano, IT (EORTC), FECMM
    • 16:40
      S10.2 The flu becomes mouldy

      Paul Verweij, NL (EORTC & EFISG), FECMM
    • 17:05
      S10.3 News from the lab

      Ana Alastruey-Izquierdo, ES (EFISG), FECMM
    • 17:30
      Discussion
  • S11: Unusual clinical manifestations of fungal infections
    • 16:15
      S11.1 Cerebral fungal infections

      Arunaloke Chakrabarti, IN, FECMM
    • 16:40
      S11.2 Abdominal fungal infections

      Matteo Bassetti, IT
    • 17:05
      S11.3 Osteo-articular fungal infections

      Olivier Lortholary, FR
    • 17:30
      S11.4* Outbreak of Saprochaete clavata sepsis in haematological patients: preliminary results of a prospective case-control study

      Giuliana Lo Cascio, Italy
  • S17: Novel biomarkers and diagnostic approaches for fungal infections
    • 16:15
      S17.1 Monoclonal antibody JF5 for aspergillosis: from BALF to immuno PET/MR

      Chris Thornton, UK
    • 16:40
      S17.2 TAFC for Aspergillosis: from imaging to Urine analysis

      Hubertus Haas, AT
    • 17:05
      S17.3 Fungus-reactive T cells for Diagnosing and Monitoring of Invasive Fungal Infections

      Philipp Köhler, DE
    • 17:30
      S17.4* Triacetylfusarinine C determination in urine samples from hematological malignancy patients: a potential new biomarker for invasive aspergillosis

      Juergen Prattes, Austria
  • 18:00
    Sponsored Integrated Symposium 3
    | More info
  • 19:30
    Sponsored reception & fingerfood